The Rationality of Antihypertensive and Oral Antidiabetic Patients with Chronic Kidney Disease with Hypertension and or Type 2 Diabetes Mellitus in RSI Siti Khadijah Palembang

Abstract

Chronic Kidney Disease (CKD) is defined as a condition of kidney damage occurring for 3 months or more with a decrease in Glomerular Filtration Rate (GFR) of less than 60 mL/min/1,73m2. The etiology of CKD includes hypertension and type 2 diabetes melitus (DM). The existance of irrational using of antihypertensive drugs and oral antidiabetics in CKD patients with hypertensive etiology and or type 2 diabetes melitus leads to research on the rationality of antihypertensive and oral antidiabetics. This study aims to evaluate the rationality of antihypertensive and or oral antidiabetics of patients with kidney disease with hypertension and or type 2 diabetes mellitus in RSI Siti Khadijah Palembang. This research was done by descriptive analysis method, data collection was done prospectively. The data obtained were 5 samples that suits exclusion criteria as well as 20 samples that suits inclusion criteria. The results of evaluation of antihypertensive drug use were found to be 100% precise indication, 100% precise dose, 95% precise patient, 90% precise drug, and 10% of patients experienced side effects. The evaluation of the use of OAD were 100% precise indication, 100% precise dose, 100% precise patient, 100% precise drug, and 100% of patients had no side effects.